Skip to main content

Animations

Charles Kenneth Meshul, PhD

Research Biologist and Professor at VA Medical Center and Departments of Behavioral Neuroscience and Pathology, Oregon Health & Science

Location: Portland, OR United States

Meshul received his PhD in 1982 in the department of anatomy and cell biology at the University of Illinois Medical Center, with an emphasis in neuroanatomy and electron microscopy. He completed his 2-year postdoctoral fellowship in the Department of Pharmacology at the University of Maryland Medical Center, with an emphasis in neurotoxins and electron microscopy. In 1984, he began work at the Portland Veterans Administration Medical Center and Oregon Health & Science University in Portland, Oregon, with an emphasis in the effects of neuroleptic drugs on the basal ganglia, utilizing both electron microscopy and pharmacology. In the late 1990’s, he switched his focus to Parkinson’s disease in pre-clinical models. Meshul has developed a new progressive pre-clinical model of the disease, whereby increasing the weekly dose of this toxin leads to a gradual loss of dopamine neurons, which correlates with deficits in motor function.


 


Associated Grants

  • Investigation of Possible Pathological Changes in Aged LRRK2 Knockout Models

    2012


  • Increased Sensitivity to the Loss of Nigrostriatal Dopamine Following Progressive MPTP Treatment in LRRK2 Mutant Small Models

    2011


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.